QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:CCJ

Cameco (CCJ) Stock Forecast, Price & News

$29.81
-0.79 (-2.58%)
(As of 06/7/2023 ET)
Compare
Today's Range
$29.72
$31.05
50-Day Range
$25.10
$30.89
52-Week Range
$20.34
$31.44
Volume
4.86 million shs
Average Volume
4.37 million shs
Market Capitalization
$12.91 billion
P/E Ratio
102.80
Dividend Yield
0.30%
Price Target
$48.75

Cameco MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
63.5% Upside
$48.75 Price Target
Short Interest
Healthy
3.53% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-8.35
Upright™ Environmental Score
News Sentiment
0.29mentions of Cameco in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
90.91%
From $0.88 to $1.68 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Basic Materials Sector

74th out of 164 stocks

Miscellaneous Metal Ores Industry

1st out of 3 stocks


CCJ stock logo

About Cameco (NYSE:CCJ) Stock

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Receive CCJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cameco and its competitors with MarketBeat's FREE daily newsletter.

CCJ Stock News Headlines

Time To Buy Uranium? Cameco Is The Top Pick
The uranium bull market shows a potential resurgence with a focus on leading stock, Cameco. Multiple catalysts hold the potential to catapult it to new heights.
Cameco (NYSE:CCJ) Rating Increased to Hold at StockNews.com
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
This Is What Whales Are Betting On Cameco
Cameco Unusual Options Activity For May 31
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Cameco Unusual Options Activity
Cameco (NYSE: CCJ)
Cameco (NYSE:CCJ) Lowered to "Sell" at StockNews.com
Cameco Target of Unusually High Options Trading (NYSE:CCJ)
Cameco (NYSE:CCJ) Upgraded by StockNews.com to "Hold"
Cameco (CCJ) Set to Announce Quarterly Earnings on Friday
Cameco (NYSE:CCJ) Upgraded by StockNews.com to "Sell"
See More Headlines

CCJ Price History

CCJ Company Calendar

Last Earnings
10/28/2021
Today
6/07/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous metal ores
Sub-Industry
N/A
Employees
1,931
Year Founded
1988

Price Target and Rating

Average Stock Price Forecast
$48.75
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$44.00
Forecasted Upside/Downside
+63.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$68.75 million
Pretax Margin
9.15%

Debt

Sales & Book Value

Annual Sales
$1.44 billion
Cash Flow
$0.54 per share
Book Value
$10.38 per share

Miscellaneous

Free Float
428,702,000
Market Cap
$12.91 billion
Optionable
Optionable
Beta
0.95

Social Links


Key Executives

  • Tim Gitzel Gitzel
    President, CEO & Non-Independent Director
  • Brian Reilly
    Chief Operating Officer & Senior Vice President
  • Grant E. Isaac
    Chief Financial Officer & Executive Vice President
  • Scott Bishop
    Director-Development & Technical Services
  • Sean A. Quinn
    Secretary, Chief Legal Officer & Senior VP













CCJ Stock - Frequently Asked Questions

Should I buy or sell Cameco stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cameco in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CCJ shares.
View CCJ analyst ratings
or view top-rated stocks.

What is Cameco's stock price forecast for 2023?

2 Wall Street analysts have issued twelve-month price objectives for Cameco's shares. Their CCJ share price forecasts range from $44.00 to $51.00. On average, they expect the company's stock price to reach $48.75 in the next year. This suggests a possible upside of 58.5% from the stock's current price.
View analysts price targets for CCJ
or view top-rated stocks among Wall Street analysts.

How have CCJ shares performed in 2023?

Cameco's stock was trading at $22.67 at the beginning of 2023. Since then, CCJ stock has increased by 35.7% and is now trading at $30.76.
View the best growth stocks for 2023 here
.

When is Cameco's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CCJ earnings forecast
.

How were Cameco's earnings last quarter?

Cameco Co. (NYSE:CCJ) issued its earnings results on Thursday, October, 28th. The basic materials company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.10. The basic materials company earned $361 million during the quarter, compared to analysts' expectations of $422.49 million. Cameco had a trailing twelve-month return on equity of 4.26% and a net margin of 7.84%. The company's revenue for the quarter was down 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.15) earnings per share.

What ETFs hold Cameco's stock?

ETFs with the largest weight of Cameco (NYSE:CCJ) stock in their portfolio include iShares North American Natural Resources ETF (IGE).iShares MSCI Intl Momentum Factor ETF (IMTM).

Is Cameco a good dividend stock?

Cameco (NYSE:CCJ) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.29%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 31.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CCJ will have a dividend payout ratio of 5.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CCJ.

What guidance has Cameco issued on next quarter's earnings?

Cameco updated its FY 2023 earnings guidance on Friday, April, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.64 billion-$1.75 billion, compared to the consensus revenue estimate of $2.42 billion.

What is Tim Gitzel's approval rating as Cameco's CEO?

37 employees have rated Cameco Chief Executive Officer Tim Gitzel on Glassdoor.com. Tim Gitzel has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Cameco own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cameco investors own include Cameco (CCO), Freeport-McMoRan (FCX), General Electric (GE), Intel (INTC), Energy Transfer (ET), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Ford Motor (F), Gilead Sciences (GILD) and Barrick Gold (GOLD).

What is Cameco's stock symbol?

Cameco trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCJ."

Who are Cameco's major shareholders?

Cameco's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include FMR LLC (4.92%), Mirae Asset Global Investments Co. Ltd. (3.17%), William Blair Investment Management LLC (2.36%), Price T Rowe Associates Inc. MD (1.51%), Keybank National Association OH (1.51%) and FIL Ltd (1.48%).

How do I buy shares of Cameco?

Shares of CCJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cameco's stock price today?

One share of CCJ stock can currently be purchased for approximately $30.76.

How much money does Cameco make?

Cameco (NYSE:CCJ) has a market capitalization of $13.32 billion and generates $1.44 billion in revenue each year. The basic materials company earns $68.75 million in net income (profit) each year or $0.29 on an earnings per share basis.

How many employees does Cameco have?

The company employs 1,931 workers across the globe.

How can I contact Cameco?

Cameco's mailing address is 2121 11TH ST W, SASKATOON A9, S7M 1J3. The official website for the company is www.cameco.com. The basic materials company can be reached via phone at (306) 956-6200 or via fax at 306-956-6201.

This page (NYSE:CCJ) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -